E-therapeutics Plc Pink Sheet Forward View
| ETXPFDelisted Stock | USD 0.13 0.00 0.00% |
E-therapeutics Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of E-therapeutics Plc's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 8th of February 2026 the relative strength index (rsi) of E-therapeutics Plc's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using E-therapeutics Plc hype-based prediction, you can estimate the value of E therapeutics Plc from the perspective of E-therapeutics Plc response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of E therapeutics Plc on the next trading day is expected to be 0.13 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. E-therapeutics Plc after-hype prediction price | USD 0.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
E-therapeutics |
E-therapeutics Plc Additional Predictive Modules
Most predictive techniques to examine E-therapeutics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for E-therapeutics using various technical indicators. When you analyze E-therapeutics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
E-therapeutics Plc Naive Prediction Price Forecast For the 9th of February
Given 90 days horizon, the Naive Prediction forecasted value of E therapeutics Plc on the next trading day is expected to be 0.13 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict E-therapeutics Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that E-therapeutics Plc's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
E-therapeutics Plc Pink Sheet Forecast Pattern
| Backtest E-therapeutics Plc | E-therapeutics Plc Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of E-therapeutics Plc pink sheet data series using in forecasting. Note that when a statistical model is used to represent E-therapeutics Plc pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 45.9194 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for E-therapeutics Plc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as E therapeutics Plc. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.E-therapeutics Plc After-Hype Price Density Analysis
As far as predicting the price of E-therapeutics Plc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in E-therapeutics Plc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of E-therapeutics Plc, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
E-therapeutics Plc Estimiated After-Hype Price Volatility
In the context of predicting E-therapeutics Plc's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on E-therapeutics Plc's historical news coverage. E-therapeutics Plc's after-hype downside and upside margins for the prediction period are 0.13 and 0.13, respectively. We have considered E-therapeutics Plc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
E-therapeutics Plc is very steady at this time. Analysis and calculation of next after-hype price of E therapeutics Plc is based on 3 months time horizon.
E-therapeutics Plc Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as E-therapeutics Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading E-therapeutics Plc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with E-therapeutics Plc, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.13 | 0.13 | 0.00 |
|
E-therapeutics Plc Hype Timeline
E therapeutics Plc is currently traded for 0.13. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. E-therapeutics is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on E-therapeutics Plc is about 0.0%, with the expected price after the next announcement by competition of 0.13. About 63.0% of the company shares are held by company insiders. The book value of E-therapeutics Plc was currently reported as 0.05. The company recorded a loss per share of 0.02. E therapeutics Plc had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be in a few days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.E-therapeutics Plc Related Hype Analysis
Having access to credible news sources related to E-therapeutics Plc's direct competition is more important than ever and may enhance your ability to predict E-therapeutics Plc's future price movements. Getting to know how E-therapeutics Plc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how E-therapeutics Plc may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KDEVF | Karolinska Development AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BSTG | Biostage | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MCURF | Mind Cure Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EOFBY | Ecofibre Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HRPMF | Herantis Pharma Oyj | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ONPPF | Oncopeptides AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MVRBF | Medivir AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TIHE | Taihe Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MSSTF | Mindset Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SYMQY | SymBio Pharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.19) | 0.00 | 0.00 | 24.71 |
E-therapeutics Plc Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with E-therapeutics Plc pink sheet to make a market-neutral strategy. Peer analysis of E-therapeutics Plc could also be used in its relative valuation, which is a method of valuing E-therapeutics Plc by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
E-therapeutics Plc Market Strength Events
Market strength indicators help investors to evaluate how E-therapeutics Plc pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading E-therapeutics Plc shares will generate the highest return on investment. By undertsting and applying E-therapeutics Plc pink sheet market strength indicators, traders can identify E therapeutics Plc entry and exit signals to maximize returns.
Story Coverage note for E-therapeutics Plc
The number of cover stories for E-therapeutics Plc depends on current market conditions and E-therapeutics Plc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that E-therapeutics Plc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about E-therapeutics Plc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in E-therapeutics Pink Sheet
If you are still planning to invest in E therapeutics Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the E-therapeutics Plc's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |